Cargando…
Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study)
BACKGROUND: Non-adherence to antidepressants generates higher costs for the treatment of depression. Little is known about the cost-effectiveness of pharmacist's interventions aimed at improving adherence to antidepressants. The study aimed to evaluate the cost-effectiveness of a community phar...
Autores principales: | Rubio-Valera, Maria, Bosmans, Judith, Fernández, Ana, Peñarrubia-María, Maite, March, Marian, Travé, Pere, Bellón, Juan A., Serrano-Blanco, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741197/ https://www.ncbi.nlm.nih.gov/pubmed/23950967 http://dx.doi.org/10.1371/journal.pone.0070588 |
Ejemplares similares
-
Correction: Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study)
por: Rubio-Valera, Maria, et al.
Publicado: (2016) -
Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol
por: Rubio-Valera, Maria, et al.
Publicado: (2009) -
Impacto de una intervención farmacéutica en la prevención de recaídas en depresión en atención primaria()
por: Rubio-Valera, María, et al.
Publicado: (2016) -
Use of Mental Health Services for Patients Diagnosed with Major Depressive Disorders in Primary Care
por: González-Suñer, Laura, et al.
Publicado: (2021) -
Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)
por: Rubio-Valera, Maria, et al.
Publicado: (2015)